Sei Investments Co. decreased its position in Steris PLC (NYSE:STE) by 12.1% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 81,376 shares of the medical equipment provider’s stock after selling 11,175 shares during the period. Sei Investments Co.’s holdings in Steris were worth $7,118,000 as of its most recent SEC filing.
A number of other institutional investors have also recently bought and sold shares of STE. Congress Asset Management Co. MA raised its holdings in Steris by 36.6% in the 4th quarter. Congress Asset Management Co. MA now owns 822,391 shares of the medical equipment provider’s stock valued at $71,935,000 after acquiring an additional 220,268 shares in the last quarter. American Century Companies Inc. raised its holdings in Steris by 14.6% in the 4th quarter. American Century Companies Inc. now owns 1,194,167 shares of the medical equipment provider’s stock valued at $104,454,000 after acquiring an additional 152,346 shares in the last quarter. Daiwa Securities Group Inc. raised its holdings in Steris by 106.7% in the 4th quarter. Daiwa Securities Group Inc. now owns 196,421 shares of the medical equipment provider’s stock valued at $17,181,000 after acquiring an additional 101,396 shares in the last quarter. Bank of Montreal Can raised its holdings in Steris by 34.4% in the 4th quarter. Bank of Montreal Can now owns 340,450 shares of the medical equipment provider’s stock valued at $29,779,000 after acquiring an additional 87,166 shares in the last quarter. Finally, West Coast Financial LLC acquired a new position in Steris in the 3rd quarter valued at approximately $7,570,000. 89.43% of the stock is owned by hedge funds and other institutional investors.
Several equities analysts have commented on the company. KeyCorp reaffirmed a “buy” rating and issued a $103.00 price target on shares of Steris in a report on Thursday, February 8th. Northcoast Research set a $102.00 target price on Steris and gave the stock a “buy” rating in a report on Thursday, February 8th. Zacks Investment Research raised Steris from a “hold” rating to a “buy” rating and set a $103.00 target price for the company in a report on Tuesday, January 23rd. Raymond James Financial reissued a “market perform” rating and issued a $100.00 target price on shares of Steris in a report on Wednesday, January 3rd. Finally, TD Securities increased their target price on Steris from C$14.00 to C$16.00 and gave the stock a “buy” rating in a report on Thursday, November 9th. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $84.80.
Steris PLC (NYSE STE) opened at $92.03 on Wednesday. Steris PLC has a twelve month low of $67.55 and a twelve month high of $93.71. The company has a quick ratio of 2.22, a current ratio of 2.82 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $7,852.69, a P/E ratio of 23.02 and a beta of 1.22.
Steris (NYSE:STE) last issued its earnings results on Wednesday, February 7th. The medical equipment provider reported $1.12 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.07 by $0.05. Steris had a return on equity of 11.57% and a net margin of 9.42%. The business had revenue of $661.90 million during the quarter, compared to analysts’ expectations of $663.17 million. During the same period in the prior year, the firm posted $0.98 EPS. Steris’s quarterly revenue was up 2.3% compared to the same quarter last year. research analysts predict that Steris PLC will post 4.13 earnings per share for the current year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 28th. Stockholders of record on Wednesday, February 28th will be issued a $0.31 dividend. The ex-dividend date is Tuesday, February 27th. This is a boost from Steris’s previous quarterly dividend of $0.21. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.35%. Steris’s dividend payout ratio is presently 43.51%.
Steris Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris PLC (NYSE:STE).
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.